Economic evaluation of HPV vaccination in Austria
Zechmeister I, Freiesleben de Blasio B, Radlberger P, Wild C, Kvas E, Garnett G, Neilson AR
Record ID 32008000046
German
Authors' objectives:
Objective: the aim of this study is to forecast effectiveness and cost effectiveness of different HPV vaccination programs in Austria. The research question is: What is the predicted long term effectiveness and cost-effectiveness of different HPV vaccination programs with respect to cervical carcinoma related diseases, given that the vaccination treatment will be introduced in addition to the current Austrian practice of cervical carcinoma screening.
Authors' recommendations:
Conclusion and policy options: Based on the results 3 partly complementary policy options are discussed: Option 1: Improvement of screening, that is, optimization of preventive measures Option 2: Vaccination under improved cost-effectiveness due to lower vaccination price Option 3: Vaccination under current condition, but with a high risk of uncertainty and high costs
Details
Project Status:
Completed
URL for project:
http://eprints.hta.lbg.ac.at/760/
Year Published:
2007
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Austria
MeSH Terms
- Costs and Cost Analysis
- Papillomavirus Infections
Contact
Organisation Name:
Ludwig Boltzmann Institute for Health Technology Assessment
Contact Address:
Ludwig Boltzmann Institute for fuer Health Technology Assessment (LBI-HTA), Garnisongasse 7/rechte Stiege Mezzanin (Top 20), 1090 Vienna, Austria. Tel: +43 1 236 8119 - 0 Fax: +43 1 236 8119 - 99
Contact Name:
tarquin.mittermayr@aihta.at
Contact Email:
office@aihta.at
Copyright:
Ludwig Boltzmann Institut fuer Health Technology Assessment (LBIHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.